PT Kimia Farma (Persero) Tbk

Jakarta Stock Exchange KAEF.JK

PT Kimia Farma (Persero) Tbk Free Cash Flow Yield on February 06, 2025: -37.35%

PT Kimia Farma (Persero) Tbk Free Cash Flow Yield is -37.35% on February 06, 2025, a -67.93% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

PT Kimia Farma (Persero) Tbk 52-week high Free Cash Flow Yield is -21.20% on March 22, 2024, which is 43.23% above the current Free Cash Flow Yield.
PT Kimia Farma (Persero) Tbk 52-week low Free Cash Flow Yield is -37.79% on June 20, 2024, which is -1.19% below the current Free Cash Flow Yield.
PT Kimia Farma (Persero) Tbk average Free Cash Flow Yield for the last 52 weeks is -30.11%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Jakarta Stock Exchange: KAEF.JK

PT Kimia Farma (Persero) Tbk

CEO	Mr. David Utama
IPO Date	July 5, 2001
Location	Indonesia
Headquarters	Jl. Veteran No.9
Employees	10,712
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Perfumes & Fragrances Personal Care

Description

PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.

Key trends

Past 5 years